http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015095095-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d11c0c9934ca37dbc3828d85fd6c8c50 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-6009 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2005-2073 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2005-2026 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-586 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2005-3123 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-3129 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-31511 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-2033 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-322 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-31 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-20 |
| filingDate | 2014-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1bcd56ce414e8c0c6ae406a6e92e4591 |
| publicationDate | 2015-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2015095095-A2 |
| titleOfInvention | Wearable medication administration device |
| abstract | A medication administration device is provided. The device has a flexible tube having an administration end, an activation end and a lumen between the ends. An administration assembly is attached to the administration end. An activation assembly is attached to the activation end. A syringe is disposed within the lumen. The syringe contains the medication and has a first end and an opposite second end. A plunger is disposed within the lumen and operatively connected to the first end of the syringe. A rupturable seal is provided to the second end of the syringe, which end is approximate to the administration end. The activation assembly activates the plunger to break the rupturable seal to establish a fluid communication between the second end of the syringe and the administration assembly. Accordingly, transportation of the medication from the syringe to the medication administration assembly through the medication administration end is allowed. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11039986-B2 |
| priorityDate | 2013-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 341.